Arcosa, Inc. (ACA) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.89%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.89% | Share-based compensation / revenue. Period ending 2026-06-30. $25.90M ÷ $2.92B × 100 ≈ 0.89% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 2.92B USD | |
| Stock-based compensation | 25.90M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 350.30M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.92B | $25.90M | $350.30M | (m) | (m) | 0.89% | (m) | (m) |
| 2026-03-31 | (m) | $2.91B | $26.30M | $348.00M | (m) | (m) | 0.90% | (m) | (m) |
| 2025-12-31 | (m) | $2.88B | $26.40M | $341.90M | (m) | (m) | 0.92% | (m) | (m) |
| 2025-09-30 | (m) | $2.83B | $25.10M | $306.10M | (m) | (m) | 0.89% | (m) | (m) |
| 2025-06-30 | (m) | $2.68B | $23.60M | $227.60M | (m) | (m) | 0.88% | (m) | (m) |
| 2025-03-31 | (m) | $2.60B | $24.30M | $200.00M | (m) | (m) | 0.93% | (m) | (m) |
| 2024-12-31 | (m) | $2.57B | $24.30M | $197.60M | (m) | (m) | 0.95% | (m) | (m) |
| 2024-09-30 | (m) | $2.49B | $24.60M | $197.20M | $42.70M | (m) | 0.99% | 4.62× | Reported |
| 2024-06-30 | (m) | $2.44B | $25.40M | $211.80M | $33.60M | (m) | 1.04% | 6.30× | Reported |
| 2024-03-31 | (m) | $2.36B | $25.10M | $195.60M | $29.30M | (m) | 1.06% | 6.68× | Reported |
| 2023-12-31 | (m) | $2.31B | $23.90M | $217.30M | $28.10M | (m) | 1.04% | 7.73× | Reported |
| 2023-09-30 | (m) | $2.23B | $21.90M | $382.60M | $28.40M | (m) | 0.98% | 13.47× | Reported |
| 2023-06-30 | (m) | $2.24B | $21.60M | $383.20M | $30.30M | (m) | 0.97% | 12.65× | Reported |
| 2023-03-31 | (m) | $2.26B | $20.20M | $389.40M | $30.90M | (m) | 0.90% | 12.60× | Reported |
| 2022-12-31 | (m) | $2.24B | $19.10M | $349.00M | $31.00M | (m) | 0.85% | 11.26× | Reported |
| 2022-09-30 | (m) | $2.26B | $20.70M | $156.50M | $30.90M | (m) | 0.91% | 5.06× | Reported |
| 2022-06-30 | (m) | $2.22B | $19.30M | $145.00M | $29.60M | (m) | 0.87% | 4.90× | Reported |
| 2022-03-31 | (m) | $2.13B | $17.70M | $119.10M | $28.50M | (m) | 0.83% | 4.18× | Reported |
| 2021-12-31 | (m) | $2.04B | $18.00M | $107.30M | $23.40M | (m) | 0.88% | 4.59× | Reported |
| 2021-09-30 | (m) | $1.97B | $18.80M | $108.50M | $18.20M | (m) | 0.95% | 5.96× | Reported |
| 2021-06-30 | (m) | $1.90B | $20.00M | $113.10M | $13.20M | (m) | 1.05% | 8.57× | Reported |
| 2021-03-31 | (m) | $1.89B | $21.00M | $129.60M | $9.40M | (m) | 1.11% | 13.79× | Reported |
| 2020-12-31 | (m) | $1.94B | $20.00M | $151.80M | $10.60M | (m) | 1.03% | 14.32× | Reported |
| 2020-09-30 | (m) | $1.92B | $17.50M | $165.50M | $10.10M | (m) | 0.91% | 16.39× | Reported |
| 2020-06-30 | (m) | $1.88B | $16.30M | $166.20M | $9.40M | (m) | 0.87% | 17.68× | Reported |
| 2020-03-31 | (m) | $1.81B | $14.90M | $160.70M | $8.20M | (m) | 0.82% | 19.60× | Reported |
| 2019-12-31 | (m) | $1.74B | $14.60M | $152.90M | $6.80M | (m) | 0.84% | 22.49× | Reported |
| 2019-09-30 | (m) | $1.66B | $13.50M | $149.10M | $6.00M | (m) | 0.81% | 24.85× | Reported |
| 2019-06-30 | (m) | $1.60B | $12.20M | $112.70M | $4.40M | (m) | 0.76% | 25.61× | Reported |
| 2019-03-31 | (m) | $1.52B | $11.10M | $101.00M | $2.80M | (m) | 0.73% | 36.07× | Reported |
| 2018-12-31 | (m) | $1.46B | $9.90M | $94.90M | $900.00K | (m) | 0.68% | 105.44× | Reported |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $1.42B | (m) | $118.50M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $1.42B | (m) | $123.30M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $1.46B | $9.00M | $131.70M | $0.00 | (m) | 0.62% | (m) | Reported |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $1.70B | $10.50M | $200.80M | $0.00 | (m) | 0.62% | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VALMONT INDUSTRIES INC (VMI) | United States | $8.988B | 22.19 |
| Proto Labs Inc (PRLB) | United States | $2.226B | 64.02 |
| INNOVATE Corp. (VATE) | United States | $0.102B | |
| TECHPRECISION CORP (TPCS) | United States | $0.053B | 108.37 |